Table 4 The most different phenotype pairs within multi-phenotype disease genes by the mLOF score
Gene | LOF-like phenotype | mLOF | non-LOF-like phenotype | mLOF |
---|---|---|---|---|
SMCHD1 | Facioscapulohumeral muscular dystrophy 2 | 0.656 | Bosma Arhinia Microphthalmia Syndrome | 0.274 |
KRAS | Cardiofaciocutaneous syndrome 2 | 0.623 | Multiple myeloma | 0.296 |
TP63 | Rapp-Hodgkin syndrome | 0.653 | Split-Hand/foot malformation 4 | 0.329 |
PRPF8 | Retinitis pigmentosa | 0.656 | Retinitis pigmentosa 13 | 0.339 |
SMARCB1 | Schwannomatosis | 0.63 | Coffin-Siris syndrome 3 | 0.318 |
GNAS | Pseudopseudohypoparathyroidism | 0.659 | Pituitary adenoma 3, multiple types, somatic | 0.346 |
BRAF | Noonan syndrome 1 | 0.632 | Multiple myeloma | 0.321 |
ABCB11 | Cholestasis, progressive familial intrahepatic 2 | 0.638 | Cholestasis, intrahepatic, of pregnancy 3 | 0.33 |
CAV3 | Long QT syndrome 9 | 0.598 | Rippling muscle disease | 0.294 |
MTOR | Renal cell carcinoma, papillary, 1, familial and somatic | 0.619 | CEBALID syndrome | 0.32 |
ADCY5 | Dyskinesia with orofacial involvement, autosomal recessive | 0.645 | Dyskinesia, familial, with facial myokymia | 0.364 |
AARS1 | Epileptic encephalopathy, early infantile, 29 | 0.644 | Charcot-Marie-Tooth disease, axonal, type 2 N | 0.366 |
LRP6 | Tooth agenesis, selective, 7 | 0.656 | Coronary artery disease, autosomal dominant 2 | 0.378 |
AIFM1 | Deafness, X-linked 5 | 0.585 | Spondyloepimetaphyseal dysplasia, X-linked, with mental deterioration | 0.311 |
ARX | Mental retardation, X-linked, with or without seizures, ARX-related | 0.637 | Corpus callosum, agenesis of, with abnormal genitalia | 0.368 |
LHCGR | Hypergonadotropic hypogonadism | 0.567 | Precocious puberty, male | 0.301 |
TWNK | Perrault syndrome 5 | 0.61 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 | 0.346 |
ACTA1 | Congenital myopathy 2B, severe infantile, autosomal recessive | 0.656 | Congenital myopathy 2 C, severe infantile, autosomal dominant | 0.395 |
TP53 | Breast cancer | 0.648 | Medulloblastoma | 0.394 |
IMPG2 | Macular dystrophy, vitelliform, 5 | 0.648 | Macular dystrophy, vitelliform, 2 | 0.395 |
HBA2 | Heinz body anemias | 0.651 | Methemoglobinemia, Alpha type | 0.406 |
SLC32A1 | Generalised epilepsy with febrile seizures plus, type 12 | 0.641 | Developmental and epileptic encephalopathy 114 | 0.397 |
SCN4A | Congenital myopathy 22 A, classic | 0.62 | Paramyotonia congenita | 0.376 |
EXT2 | Exostoses, multiple, type II | 0.633 | Ovarian cancer | 0.395 |
RECQL4 | RAPADILINO syndrome | 0.656 | Ovarian cancer | 0.422 |
POLR3B | Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism | 0.607 | Charcot-Marie-Tooth disease, demyelinating, type 1I | 0.385 |
APOE | Lipoprotein glomerulopathy | 0.539 | Hyperlipoproteinemia, type III | 0.316 |
NPR2 | Acromesomelic dysplasia, Maroteaux type | 0.616 | Short stature with nonspecific skeletal abnormalities | 0.395 |
PRNP | Gerstmann-Straussler disease | 0.552 | Creutzfeldt-Jakob disease | 0.331 |
FLNA | Cardiac valvular dysplasia, X-linked | 0.652 | Otopalatodigital syndrome, type I | 0.432 |
TTN | Cardiomyopathy, dilated, 1 G | 0.584 | Myopathy, myofibrillar, 9, with early respiratory failure | 0.365 |
SDHD | Mitochondrial complex II deficiency, nuclear type 3 | 0.634 | Pheochromocytoma | 0.417 |
BEST1 | Bestrophinopathy, autosomal recessive | 0.598 | Vitreoretinochoroidopathy | 0.382 |
MECP2 | Rett syndrome | 0.615 | Mental retardation, X-linked, syndromic 13 | 0.399 |
TSHR | Hypothyroidism, congenital, nongoitrous, 1 | 0.594 | Ovarian cancer | 0.379 |
TRPV4 | Metatropic dysplasia | 0.568 | Hereditary motor and sensory neuropathy, type IIC | 0.355 |